EUXS:LSE:LSE-iShares MSCI Europe Ex UK GBP (GBX)

ETF | Others |

Last Closing

USD 759.5

Change

+3.25 (+0.43)%

Market Cap

USD 0.14B

Volume

5.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.32 (-0.91%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.06 (+0.33%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.24%)

USD 266.08B
0QZO:LSE 0QZO

+1.00 (+0.92%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

-0.57 (-0.33%)

USD 202.26B
0R24:LSE Intel Corp.

+0.19 (+0.89%)

USD 196.14B

ETFs Containing EUXS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.61% 80% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.61% 80% B- 75% C
Trailing 12 Months  
Capital Gain 12.03% 54% F 59% D-
Dividend Return 0.02% 15% F 14% F
Total Return 12.05% 52% F 57% F
Trailing 5 Years  
Capital Gain 33.79% 57% F 67% D+
Dividend Return 0.11% 16% F 26% F
Total Return 33.90% 55% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 10.35% 63% D 67% D+
Dividend Return 10.47% 62% D 66% D+
Total Return 0.12% 38% F 41% F
Risk Return Profile  
Volatility (Standard Deviation) 14.24% 50% F 68% D+
Risk Adjusted Return 73.49% 74% C 84% B
Market Capitalization 0.14B 56% F 31% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.